Decarbonizing clinical trials: Where sustainability meets operational excellence
Clinical trials, or the study of new tests and treatments for human health outcomes are essential for advancing patient care.
Clinical trials, or the study of new tests and treatments for human health outcomes are essential for advancing patient care.
Power, water, materials, and infrastructure, not compute, will determine which companies scale AI successfully and which fall behind. While the focus remains on models and breakthroughs, the real bottlenecks are emerging across the physical value chain that underpins AI.
This article outlines practical actions leaders are taking to turn the targets from aspirational statements into operational reality and financial outperformance.
How semiconductor industry is turning decarbonization ambition into action across materials, clean electricity, gas, and abatement.
Why CFO-grade metrics are essential to proving the business value of sustainability - and how companies can quantify ESG initiatives to drive returns.
The construction and expansion of data centers are material and carbon intensive, leaving behind an outsized environmental footprint.
Due to high API concentrations, direct releases can have significant local impacts on water quality and health if these discharges are not adequately treated.
Value creation from corporate and investor Net Zero strategies in the coming years will move beyond own operations to focus on Scope 3 emissions.
While more private sector organizations than ever before are engaged in sustainability efforts, it has become increasingly more difficult to do this type of work.
The ERM Sustainability Institute generates actionable insight that helps companies understand and navigate the risks and opportunities created by the sustainability transformation.
